Terms: = Liver cancer AND NUTM2A, ENSG00000184923, Q5VT03, Q8IVF1, KIAA2020, 728118, FAM22A
2 results:
1. LncRNA nutm2a-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract] [Full Text] [Related]
2. Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis.
Wang X; Wang J; Lyu L; Gao X; Cai Y; Tang B
Sci Rep; 2022 Jul; 12(1):11161. PubMed ID: 35778520
[TBL] [Abstract] [Full Text] [Related]
